AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. WLKP
  4. [Form 4] WESTLAKE CHEMICAL PARTNERS LP Insider Trading Activity

[Form 4] WESTLAKE CHEMICAL PARTNERS LP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Westlake Chemical Partners LP (WLKP) filed a Form 4 reporting insider activity by director Lisa A. Friel. On 08-06-2025 she received 5,005 phantom units, each economically equivalent to a common unit. On 08-07-2025 she exercised 4,882 of those phantom units into common units (Code M) and sold 2,441 units at $21.96 (Code D). After the transactions she directly owns 7,163 common units.

  • Approximate gross value: ~US$107 k (exercise) with ~US$53 k in sale proceeds.
  • No phantom units remain; all derivative positions were converted or settled.
  • Friel remains a director of the GP, maintaining equity alignment with unitholders.

Westlake Chemical Partners LP (WLKP) ha depositato un Modulo 4 segnalando l'attivit脿 interna della direttrice Lisa A. Friel. Il 08-06-2025 ha ricevuto 5.005 unit脿 fantasma, ciascuna con valore economico equivalente a un'unit脿 comune. Il 08-07-2025 ha esercitato 4.882 di queste unit脿 fantasma trasformandole in unit脿 comuni (Codice M) e ha venduto 2.441 unit脿 a $21,96 (Codice D). Dopo queste operazioni detiene direttamente 7.163 unit脿 comuni.

  • Valore lordo approssimativo: ~107.000 USD (esercizio) con ~53.000 USD ricavati dalla vendita.
  • Non rimangono unit脿 fantasma; tutte le posizioni derivate sono state convertite o liquidate.
  • Friel continua a essere direttrice del GP, mantenendo l'allineamento patrimoniale con gli azionisti.

Westlake Chemical Partners LP (WLKP) present贸 un Formulario 4 reportando actividad interna de la directora Lisa A. Friel. El 08-06-2025 谤别肠颈产颈贸 5,005 unidades fantasma, cada una con valor econ贸mico equivalente a una unidad com煤n. El 08-07-2025 别箩别谤肠颈贸 4,882 de esas unidades fantasma convirti茅ndolas en unidades comunes (C贸digo M) y 惫别苍诲颈贸 2,441 unidades a $21.96 (C贸digo D). Tras las transacciones posee directamente 7,163 unidades comunes.

  • Valor bruto aproximado: ~107,000 USD (ejercicio) con ~53,000 USD en ingresos por ventas.
  • No quedan unidades fantasma; todas las posiciones derivadas fueron convertidas o liquidadas.
  • Friel contin煤a siendo directora del GP, manteniendo la alineaci贸n accionarial con los tenedores de unidades.

Westlake Chemical Partners LP(WLKP)電� 鞚挫偓 Lisa A. Friel鞚� 雮措秬鞛� 頇滊彊鞚� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 2025雲� 8鞗� 6鞚�, 攴鸽厐電� 臧侁皝 氤错喌欤� 雼渼鞕� 瓴届牅鞝� 臧�旃橁皜 霃欖澕頃� 5,005臧滌潣 韺厐 鞙犽嫑鞚� 氚涭晿鞀惦媹雼�. 2025雲� 8鞗� 7鞚�鞐愲姅 攴� 欷� 4,882臧滌潣 韺厐 鞙犽嫑鞚� 氤错喌欤� 雼渼搿� 頄夓偓(旖旊摐 M)頃橁碃, 2,441 雼渼毳� 欤茧嫻 $21.96鞐� 毵る弰(旖旊摐 D)頄堨姷雼堧嫟. 瓯半灅 頉� 攴鸽厐電� 歆侅爲 7,163臧滌潣 氤错喌欤� 雼渼毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

  • 雽�霝奠爜鞚� 齑� 臧�旃橂姅 頄夓偓搿� 鞎� 107,000雼煬, 韺愲Г 靾橃澋鞚� 鞎� 53,000雼煬鞛呺媹雼�.
  • 雮晞鞛堧姅 韺厐 鞙犽嫑鞚� 鞐嗢溂氅�, 氇摖 韺岇儩 韽靺橃澊 鞝勴櫂 霕愲姅 鞝曥偘霅橃棃鞀惦媹雼�.
  • Friel鞚� GP 鞚挫偓歆侅潉 鞙犾頃橂┌ 鞙犽嫑 氤挫湢鞛愲摛瓿检潣 歆�攵� 鞝曤牞鞚� 瓿勳啀頃橁碃 鞛堨姷雼堧嫟.

Westlake Chemical Partners LP (WLKP) a d茅pos茅 un formulaire 4 rapportant une activit茅 d鈥檌niti茅 de la directrice Lisa A. Friel. Le 06-08-2025, elle a re莽u 5 005 unit茅s fant么mes, chacune 茅conomiquement 茅quivalente 脿 une unit茅 ordinaire. Le 07-08-2025, elle a 别虫别谤肠茅 4 882 de ces unit茅s fant么mes en unit茅s ordinaires (Code M) et a vendu 2 441 unit茅s 脿 21,96 $ (Code D). Apr猫s ces transactions, elle d茅tient directement 7 163 unit茅s ordinaires.

  • Valeur brute approximative : ~107 000 $ US (exercice) avec ~53 000 $ US de produit de la vente.
  • Aucune unit茅 fant么me restante ; toutes les positions d茅riv茅es ont 茅t茅 converties ou r茅gl茅es.
  • Friel reste directrice du GP, maintenant un alignement des int茅r锚ts avec les porteurs d鈥檜nit茅s.

Westlake Chemical Partners LP (WLKP) reichte ein Formular 4 ein, das Insider-Aktivit盲ten der Direktorin Lisa A. Friel meldet. Am 06.08.2025 erhielt sie 5.005 Phantom-Einheiten, die jeweils wirtschaftlich einer Stammaktie entsprechen. Am 07.08.2025 眉产迟别 sie 4.882 dieser Phantom-Einheiten in Stammaktien aus (Code M) und verkaufte 2.441 Einheiten zu je 21,96 $ (Code D). Nach den Transaktionen besitzt sie direkt 7.163 Stammaktien.

  • Ungef盲hres Bruttovolumen: ca. 107.000 US-Dollar (Aus眉bung) mit ca. 53.000 US-Dollar Erl枚s aus dem Verkauf.
  • Keine Phantom-Einheiten verbleiben; alle derivativen Positionen wurden umgewandelt oder abgewickelt.
  • Friel bleibt Direktorin des GP und h盲lt somit eine Beteiligung im Einklang mit den Anteilseignern.
Positive
  • Director increased direct ownership to 7,163 common units, indicating continued equity alignment.
  • All derivative positions settled, simplifying the insider鈥檚 capital structure and reducing overhang.
Negative
  • Partial sale of 2,441 units at $21.96 may be viewed as limited insider profit-taking.
  • Transaction size is immaterial; unlikely to influence WLKP鈥檚 valuation or liquidity.

Insights

TL;DR: Small, routine option conversion; director keeps half of shares鈥攎ildly positive for alignment, but transaction size is immaterial to WLKP.

The grant of 5,005 phantom units and subsequent conversion suggests normal board compensation cadence. Retaining 2,441 newly issued units lifts Friel鈥檚 direct stake to 7,163, modestly increasing insider ownership. Disposal of the remaining half at $21.96 likely covers tax obligations rather than signaling bearish sentiment. Dollar amounts (<$0.2 m) are negligible relative to WLKP鈥檚 market cap, so market impact is limited. Overall, the filing is neutral from a valuation standpoint but provides a marginal positive governance signal through continued insider alignment.

Westlake Chemical Partners LP (WLKP) ha depositato un Modulo 4 segnalando l'attivit脿 interna della direttrice Lisa A. Friel. Il 08-06-2025 ha ricevuto 5.005 unit脿 fantasma, ciascuna con valore economico equivalente a un'unit脿 comune. Il 08-07-2025 ha esercitato 4.882 di queste unit脿 fantasma trasformandole in unit脿 comuni (Codice M) e ha venduto 2.441 unit脿 a $21,96 (Codice D). Dopo queste operazioni detiene direttamente 7.163 unit脿 comuni.

  • Valore lordo approssimativo: ~107.000 USD (esercizio) con ~53.000 USD ricavati dalla vendita.
  • Non rimangono unit脿 fantasma; tutte le posizioni derivate sono state convertite o liquidate.
  • Friel continua a essere direttrice del GP, mantenendo l'allineamento patrimoniale con gli azionisti.

Westlake Chemical Partners LP (WLKP) present贸 un Formulario 4 reportando actividad interna de la directora Lisa A. Friel. El 08-06-2025 谤别肠颈产颈贸 5,005 unidades fantasma, cada una con valor econ贸mico equivalente a una unidad com煤n. El 08-07-2025 别箩别谤肠颈贸 4,882 de esas unidades fantasma convirti茅ndolas en unidades comunes (C贸digo M) y 惫别苍诲颈贸 2,441 unidades a $21.96 (C贸digo D). Tras las transacciones posee directamente 7,163 unidades comunes.

  • Valor bruto aproximado: ~107,000 USD (ejercicio) con ~53,000 USD en ingresos por ventas.
  • No quedan unidades fantasma; todas las posiciones derivadas fueron convertidas o liquidadas.
  • Friel contin煤a siendo directora del GP, manteniendo la alineaci贸n accionarial con los tenedores de unidades.

Westlake Chemical Partners LP(WLKP)電� 鞚挫偓 Lisa A. Friel鞚� 雮措秬鞛� 頇滊彊鞚� 氤搓碃頃橂姅 Form 4毳� 鞝滌稖頄堨姷雼堧嫟. 2025雲� 8鞗� 6鞚�, 攴鸽厐電� 臧侁皝 氤错喌欤� 雼渼鞕� 瓴届牅鞝� 臧�旃橁皜 霃欖澕頃� 5,005臧滌潣 韺厐 鞙犽嫑鞚� 氚涭晿鞀惦媹雼�. 2025雲� 8鞗� 7鞚�鞐愲姅 攴� 欷� 4,882臧滌潣 韺厐 鞙犽嫑鞚� 氤错喌欤� 雼渼搿� 頄夓偓(旖旊摐 M)頃橁碃, 2,441 雼渼毳� 欤茧嫻 $21.96鞐� 毵る弰(旖旊摐 D)頄堨姷雼堧嫟. 瓯半灅 頉� 攴鸽厐電� 歆侅爲 7,163臧滌潣 氤错喌欤� 雼渼毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.

  • 雽�霝奠爜鞚� 齑� 臧�旃橂姅 頄夓偓搿� 鞎� 107,000雼煬, 韺愲Г 靾橃澋鞚� 鞎� 53,000雼煬鞛呺媹雼�.
  • 雮晞鞛堧姅 韺厐 鞙犽嫑鞚� 鞐嗢溂氅�, 氇摖 韺岇儩 韽靺橃澊 鞝勴櫂 霕愲姅 鞝曥偘霅橃棃鞀惦媹雼�.
  • Friel鞚� GP 鞚挫偓歆侅潉 鞙犾頃橂┌ 鞙犽嫑 氤挫湢鞛愲摛瓿检潣 歆�攵� 鞝曤牞鞚� 瓿勳啀頃橁碃 鞛堨姷雼堧嫟.

Westlake Chemical Partners LP (WLKP) a d茅pos茅 un formulaire 4 rapportant une activit茅 d鈥檌niti茅 de la directrice Lisa A. Friel. Le 06-08-2025, elle a re莽u 5 005 unit茅s fant么mes, chacune 茅conomiquement 茅quivalente 脿 une unit茅 ordinaire. Le 07-08-2025, elle a 别虫别谤肠茅 4 882 de ces unit茅s fant么mes en unit茅s ordinaires (Code M) et a vendu 2 441 unit茅s 脿 21,96 $ (Code D). Apr猫s ces transactions, elle d茅tient directement 7 163 unit茅s ordinaires.

  • Valeur brute approximative : ~107 000 $ US (exercice) avec ~53 000 $ US de produit de la vente.
  • Aucune unit茅 fant么me restante ; toutes les positions d茅riv茅es ont 茅t茅 converties ou r茅gl茅es.
  • Friel reste directrice du GP, maintenant un alignement des int茅r锚ts avec les porteurs d鈥檜nit茅s.

Westlake Chemical Partners LP (WLKP) reichte ein Formular 4 ein, das Insider-Aktivit盲ten der Direktorin Lisa A. Friel meldet. Am 06.08.2025 erhielt sie 5.005 Phantom-Einheiten, die jeweils wirtschaftlich einer Stammaktie entsprechen. Am 07.08.2025 眉产迟别 sie 4.882 dieser Phantom-Einheiten in Stammaktien aus (Code M) und verkaufte 2.441 Einheiten zu je 21,96 $ (Code D). Nach den Transaktionen besitzt sie direkt 7.163 Stammaktien.

  • Ungef盲hres Bruttovolumen: ca. 107.000 US-Dollar (Aus眉bung) mit ca. 53.000 US-Dollar Erl枚s aus dem Verkauf.
  • Keine Phantom-Einheiten verbleiben; alle derivativen Positionen wurden umgewandelt oder abgewickelt.
  • Friel bleibt Direktorin des GP und h盲lt somit eine Beteiligung im Einklang mit den Anteilseignern.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Friel Lisa A.
(Last) (First) (Middle)
2801 POST OAK BLVD., STE. 600
(Street)
HOUSTON TX 77056
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Westlake Chemical Partners LP [ WLKP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Units 08/07/2025 M 4,882 A (1) 9,604 D
Common Units 08/07/2025 D 2,441 D $21.96 7,163 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Units (1) 08/06/2025 A 5,005 08/06/2026 09/06/2026 Common Units 5,005 $0 0 D
Phantom Units (1) 08/07/2025 M 4,882 08/07/2025 09/07/2025 Common Units 4,882 $0 0 D
Explanation of Responses:
1. Each Phantom Unit is the economic equivalent of one Common Unit of the Issuer.
Remarks:
Ms. Friel is a Director of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP.
Lisa Friel by J Feng POA 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many WLKP units did the director acquire and sell?

Lisa A. Friel acquired 4,882 units via conversion and sold 2,441 at $21.96, retaining 2,441 units.

What is the director鈥檚 total WLKP ownership after the Form 4?

She now directly holds 7,163 common units of Westlake Chemical Partners LP.

Were any derivative securities still outstanding after the transactions?

No. All recorded phantom units were either granted or converted; 0 derivative units remain.

Does the filing indicate a 10b5-1 trading plan?

The form does not mark the 10b5-1 checkbox, so these trades were not executed under a pre-arranged plan.

What was the sale price of WLKP units in the reported transaction?

Units were sold at $21.96 per unit on 08-07-2025.
Stock WLKP logo
Westlake Chem Partners Lp

NYSE:WLKP

WLKP Rankings

#3896 Ranked by Market Cap
#279 Ranked by Dividends

WLKP Latest News

Aug 5, 2025
Westlake Chemical Partners LP Announces Second Quarter 2025 Results
Jul 30, 2025
Westlake Chemical Partners LP Announces Second Quarter 2025 Distribution
Jul 22, 2025
Westlake Chemical Partners Announce Second Quarter 2025 Earnings Conference Call
May 2, 2025
Westlake Chemical Partners LP Announces First Quarter 2025 Results
Apr 30, 2025
Westlake Chemical Partners LP Announces First Quarter 2025 Distribution

WLKP Latest SEC Filings

Aug 8, 2025
[Form 4] WESTLAKE CHEMICAL PARTNERS LP Insider Trading Activity
Aug 8, 2025
[Form 4] WESTLAKE CHEMICAL PARTNERS LP Insider Trading Activity
Aug 7, 2025
[Form 3] WESTLAKE CHEMICAL PARTNERS LP Initial Statement of Beneficial Ownership
Aug 6, 2025
[10-Q] WESTLAKE CHEMICAL PARTNERS LP Quarterly Earnings Report
Aug 5, 2025
[8-K] WESTLAKE CHEMICAL PARTNERS LP Reports Material Event

WLKP Stock Data

772.43M
19.27M
44.8%
33.6%
0.28%
Chemicals
Industrial Organic Chemicals
United States
HOUSTON